X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.

Hanling Wang | Ni Li | Qiuli Liu | Jiacheng Guo | Qiang Pan | Bisheng Cheng | Junyu Xu | Baijun Dong | Guanjie Yang | Bin Yang | Xuege Wang | Yongqiang Gu | Guoying Zhang | Yannan Lian | Wei Zhang | Mingyu Zhang | Tianyi Li | Yi Zang | Minjia Tan | Qintong Li | Xiaoming Wang | Zhengquan Yu | Jun Jiang | Hai Huang | Jun Qin
Cancer cell | 2023

Lineage plasticity causes therapeutic resistance; however, it remains unclear how the fate conversion and phenotype switching of cancer-associated fibroblasts (CAFs) are implicated in disease relapse. Here, we show that androgen deprivation therapy (ADT)-induced SPP1+ myofibroblastic CAFs (myCAFs) are critical stromal constituents that drive the development of castration-resistant prostate cancer (CRPC). Our results reveal that SPP1+ myCAFs arise from the inflammatory CAFs in hormone-sensitive PCa; therefore, they represent two functional states of an otherwise ontogenically identical cell type. Antiandrogen treatment unleashes TGF-β signaling, resulting in SOX4-SWI/SNF-dependent CAF phenotype switching. SPP1+ myCAFs in turn render PCa refractory to ADT via an SPP1-ERK paracrine mechanism. Importantly, these sub-myCAFs are associated with inferior therapeutic outcomes, providing the rationale for inhibiting polarization or paracrine mechanisms to circumvent castration resistance. Collectively, our results highlight that therapy-induced phenotypic switching of CAFs is coupled with disease progression and that targeting this stromal component may restrain CRPC.

Pubmed ID: 37352863 RIS Download

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Androgen Receptor antibody [ER179(2)] (antibody)

RRID:AB_10865716

This monoclonal targets Androgen Receptor antibody [ER179(2)]

View all literature mentions

RSK1 p90 (phospho S380) antibody [E239] (antibody)

RRID:AB_777767

This monoclonal targets RSK1 p90 (phospho S380)

View all literature mentions

H3K27ac-human (antibody)

RRID:AB_2118291

This polyclonal targets H3K27ac

View all literature mentions

Recombinant Anti-Collagen I antibody [EPR22894-89] (antibody)

RRID:AB_2922767

This recombinant monoclonal targets Collagen I

View all literature mentions

Mouse Osteopontin (OPN) Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2194992

This polyclonal targets Mouse Osteopontin (OPN) Affinity Purified Ab

View all literature mentions

ARID1A/BAF250A (D2A8U) Rabbit mAb #12354 (antibody)

RRID:AB_2637010

This monoclonal targets ARID1A/BAF250A

View all literature mentions

RSK1 p90 antibody [E4] (antibody)

RRID:AB_779068

This monoclonal targets RSK1 p90

View all literature mentions

HER3/ErbB3 (1B2E) Rabbit mAb (antibody)

RRID:AB_10691324

This monoclonal targets Erbb3

View all literature mentions

Phospho-Akt (Thr308) (244F9) Rabbit mAb (antibody)

RRID:AB_331163

This monoclonal targets Phospho-Akt (Thr308) (244F9) Rabbit mAb

View all literature mentions

Akt (pan) (C67E7) Rabbit mAb (antibody)

RRID:AB_915783

This monoclonal targets Akt (pan) (C67E7) Rabbit mAb

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

p44/42 MAPK (Erk1/2) Antibody (antibody)

RRID:AB_330744

This polyclonal targets p44/42 MAPK (Erk1/2)

View all literature mentions

Phospho-Smad3 (Ser423/425) (C25A9) Rabbit mAb (antibody)

RRID:AB_2193207

This monoclonal targets Phospho-Smad3 (Ser423/425) (C25A9) Rabbit mAb

View all literature mentions

Phospho-Smad2 (Ser465/467) Antibody (antibody)

RRID:AB_331673

This polyclonal targets Phospho-Smad2 (Ser465/467)

View all literature mentions

Smad3 Antibody (antibody)

RRID:AB_2286450

This polyclonal targets Smad3

View all literature mentions

Smad2 (D43B4) XP Rabbit mAb (antibody)

RRID:AB_10626777

This monoclonal targets Smad2 (D43B4) XP Rabbit mAb

View all literature mentions

Beta Actin antibody (antibody)

RRID:AB_2687938

This monoclonal targets Beta Actin

View all literature mentions

p53 (1C12) Mouse mAb (antibody)

RRID:AB_331743

This monoclonal targets p53 (1C12) Mouse mAb

View all literature mentions

HB-EGF (H-1) (antibody)

RRID:AB_10708568

This monoclonal targets HB-EGF (H-1)

View all literature mentions

VEGF-C (E-6) (antibody)

RRID:AB_11012156

This monoclonal targets VEGF-C (E-6)

View all literature mentions

FITC anti-mouse CD45 (antibody)

RRID:AB_312973

This monoclonal targets CD45

View all literature mentions

BRG1 antibody [EPNCIR111A] (antibody)

RRID:AB_10861578

This monoclonal targets BRG1 antibody [EPNCIR111A]

View all literature mentions

Monoclonal Anti-Actin, α-Smooth Muscle (antibody)

RRID:AB_476701

This monoclonal targets Actin, α-Smooth Muscle

View all literature mentions

GFP-avictoria (antibody)

RRID:AB_303395

This polyclonal targets GFP

View all literature mentions

Androgen Receptor (antibody)

RRID:AB_1563391

This unknown targets ND

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb (antibody)

RRID:AB_2315112

This monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)

View all literature mentions

TGF Beta 1 antibody (antibody)

RRID:AB_2811115

This polyclonal targets TGF Beta 1

View all literature mentions

PDGF Receptor alpha (D1E1E) XP Rabbit mAb (antibody)

RRID:AB_2162345

This monoclonal targets PDGF Receptor alpha

View all literature mentions

OPN (AKm2A1) (antibody)

RRID:AB_2194997

This monoclonal targets OPN (AKm2A1)

View all literature mentions

Myc-CaP (cell line)

RRID:CVCL_J703

Cell line Myc-CaP is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

LNCaP C4-2 (cell line)

RRID:CVCL_4782

Cell line LNCaP C4-2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

LAPC-4 (cell line)

RRID:CVCL_4744

Cell line LAPC-4 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

PC-3 (cell line)

RRID:CVCL_0035

Cell line PC-3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T/17 (cell line)

RRID:CVCL_1926

Cell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions